Editorial: Molecular MRD testing in patients with acute myeloid leukemia

被引：0
|
作者：
Blackmon, Amanda L. [1 ]
Grunwald, Michael R. [2 ]
机构：
[1] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA 91010 USA
[2] Wake Forest Univ, Atrium Hlth, Levine Canc Inst, Dept Hematol Oncol & Blood Disorders,Sch Med, Charlotte, NC USA
来源：
BONE MARROW TRANSPLANTATION | 2025年 / 60卷 / 02期
关键词：
MINIMAL RESIDUAL DISEASE; BLINATUMOMAB; ADULTS;
D O I：
10.1038/s41409-024-02493-y
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：119 / 121
页数：3
相关论文
共 50 条
  • [21] IMPACT OF OLIGO ZONALITY ON ACCURATE MRD ASSESSMENT IN ACUTE MYELOID LEUKEMIA
    Ngai, Lok Lam
    Heidinga, Maaike
    Cloos, Jacqueline
    ANNALS OF HEMATOLOGY, 2023, 102 (SUPPL 1) : S77 - S78
  • [22] The role of MRD in pediatric Acute Myeloid Leukemia: two case reports
    Karow, Axel
    Ammann, Roland A.
    Bacher, Ulrike
    Gerber, Nicolas
    Roessler, Jochen
    Bourquin, Jean-Pierre
    SWISS MEDICAL WEEKLY, 2018, 148 : 8S - 8S
  • [23] How we use molecular minimal residual disease (MRD) testing in acute myeloid leukaemia (AML)
    Dillon, Richard
    Potter, Nicola
    Freeman, Sylvie
    Russell, Nigel
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (02) : 231 - 244
  • [24] Editorial: Precision medicine for acute myeloid leukemia
    Marconi, Giovanni
    Guolo, Fabio
    Nanni, Jacopo
    Papayannidis, Cristina
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [25] Molecular Characterization of Acute Myeloid Leukemia Patients with Normal Karyotype
    Nazha, Aziz
    Meggendorfer, Manja
    Mukherjee, Sudipto
    Walter, Wencke
    Hutter, Stephan
    Makhoul, Ahed
    Hirsch, Cassandra M.
    Przychodzen, Bartlomiej P.
    Carraway, Hetty E.
    Nagata, Yasunobu
    Guan, Yihong
    Kuzmanovic, Teodora
    Hasipek, Metis
    Jha, Babal K.
    Maciejewski, Jaroslaw P.
    Haferlach, Claudia
    Sekeres, Mikkael A.
    Haferlach, Torsten
    BLOOD, 2018, 132
  • [26] Development of Circulating Tumor DNA (ctDNA) for Molecular Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML)
    Gunaratne, Ruwan
    Zhou, Crystal
    Tai, Jesse W.
    Schwede, Matthew
    Tanaka, Kailee
    Alkaitis, Matthew
    Yin, Raymond
    Sworder, Brian J.
    Mannis, Gabriel
    Majeti, Ravindra
    Khodadoust, Michael S.
    Kurtz, David M.
    Zhang, Tian Y.
    BLOOD, 2023, 142
  • [27] Editorial: Immunotherapy in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)
    Jamy, Omer
    Zhou, Fuling
    Zeidner, Joshua
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [28] Molecular targeting in acute myeloid leukemia
    Seah H. Lim
    Patrycja M. Dubielecka
    Vikram M. Raghunathan
    Journal of Translational Medicine, 15
  • [29] Molecular diagnosis of acute myeloid leukemia
    Watt, Christopher D.
    Bagg, Adam
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2010, 10 (08) : 993 - 1012
  • [30] Molecular biomarkers in acute myeloid leukemia
    Prada-Arismendy, Jeanette
    Arroyave, Johanna C.
    Rothlisberger, Sarah
    BLOOD REVIEWS, 2017, 31 (01) : 63 - 76
12345